Clinical Trials
Learn More

AVAX's International
Subsidiary

Patient information on
AVAX's Phase III
Registration Study MVALDI

Clinical News

AVAX Presents Results of a Dose-Response Study of MVax® at American Society of Clinical Oncology (ASCO)

AVAX Technologies Announces Initiation of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax®)


© 2011 AVAX Technologies, Inc. | Terms
Site design: Schenkel/Stegman
Management Board of Directors
Product Pipeline & Overview Publications

Overview SEC Filings Information Request Press Releases
Home | Site Map | Contact Us